Overview
In 2019, following a Madras High Court order, the Tamil Nadu government issued a gazette order that bans non‑life‑threatening sex‑reassignment surgery for intersex children. The ban requires a multidisciplinary panel to decide if a surgery is medically essential. Experts now argue that the state must also strengthen its genetic testing facilities to improve diagnosis and management of DSD cases.
Key Developments
- 2019: Gazette order bans genital‑normalising surgeries unless life‑threatening.
- Panel composition: paediatric surgeon/urologist, endocrinologist, social worker/psychologist/intersex activist, and a government representative.
- Only one of 38 medical colleges (Institute of Child Health, Egmore) has a dedicated genetics department.
- Current cost of outsourced genetic tests: ₹1,500‑₹2,500 for karyotyping; ₹8,000‑₹10,000 for advanced panels.
Important Facts
Hospitals in Tamil Nadu see about one to two intersex cases per month. Surgical intervention is limited to emergencies such as certain forms of CAH. Experts highlight two major gaps:
- Karyotyping is not available in most government hospitals and must be outsourced.
- Advanced tests like NGS are absent, limiting precise subtype identification.
Without in‑house facilities, families bear high out‑of‑pocket costs, and clinicians lack timely data for counselling on cancer risk, fertility, and gender identity.
Exam Relevance
The issue touches multiple GS papers:
- GS2 (Polity): State‑level health policy, role of the NHRC and judicial interventions.
- GS3 (Science & Technology): Need for genomic infrastructure, cost‑effective public health labs, and technology adoption.
- GS4 (Ethics): Rights of intersex persons, bodily autonomy, and ethical considerations in medical decision‑making.
Way Forward
Experts propose a three‑pronged approach:
- Infrastructure upgrade: Establish at least two additional centres of excellence with in‑house karyotyping and NGS capabilities.
- Human resource development: Train clinical geneticists and lab technicians; embed a geneticist in every multidisciplinary DSD team.
- Policy formulation: Draft a national, evidence‑based protocol for intersex care that aligns with human‑rights standards and ensures insurance coverage for essential genetic tests.
Strengthening public genetic services will reduce reliance on expensive private labs, improve diagnostic accuracy, and support ethical, rights‑based care for intersex children across India.